loading...| Preferred Name |
epoetin beta |
|
| Synonyms |
Recormon EPOB NeoRecormon |
|
| Definitions |
A recombinant therapeutic agent that is chemically identical to or similar to the endogenous cytokine human erythropoietin (EPO). Produced primarily by cells of the peritubular capillary endothelium of the kidney in response to hypoxia, circulating EPO binds to EPO receptors on the surface of committed erythroid progenitors in the bone marrow resulting in their replication and maturation into functional erythrocytes. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C26639" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C26639" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000257861 |
|
| altLabel |
Recormon EPOB NeoRecormon |
|
| cui |
C0357131 C0376540 |
|
| Date last modified |
2015-12-31 |
|
| definition |
A recombinant therapeutic agent that is chemically identical to or similar to the endogenous cytokine human erythropoietin (EPO). Produced primarily by cells of the peritubular capillary endothelium of the kidney in response to hypoxia, circulating EPO binds to EPO receptors on the surface of committed erythroid progenitors in the bone marrow resulting in their replication and maturation into functional erythrocytes. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C26639" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C26639" NCI Thesaurus) |
|
| Legacy PDQ ID |
11467 |
|
| LT |
TRD |
|
| NCI ID |
C26639 |
|
| notation |
CDR0000257861 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
epoetin beta |
|
| tui |
T116 T121 |